Jane Street’s Audentes Therapeutics, Inc BOLD Stock Holding History

Jane Street’s Portfolio BOLD Stock Details BOLD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-7,307	Closed	-$437K	–	6406
2019 Q4	$437K	Sell	7,307 -1,731	-19%	-$65K	﹤0.01%	3847
2019 Q3	$254K	Buy	+9,038	New	+$308K	﹤0.01%	4355

Jane Street's BOLD Position: Q1 2020 in Review

Jane Street sold out of Audentes Therapeutics, Inc (BOLD) in Q1 2020, closing a stake of 7,307 shares — an estimated $437K sold.

Jane Street first reported a position in BOLD in Q3 2019 and held it in 2 quarters. The position peaked at $437K in Q4 2019. 0 funds tracked by Wall St. Rank hold BOLD as of Q1 2020.

Jane Street reported no remaining Audentes Therapeutics, Inc position as of Q1 2020 after selling out during the quarter.
Jane Street sold 7,307 Audentes Therapeutics, Inc shares in Q1 2020, an estimated $437K.
Jane Street first reported a position in Audentes Therapeutics, Inc in Q3 2019 and held it in 2 quarters.
Jane Street's Audentes Therapeutics, Inc position peaked at $437K in Q4 2019.
0 funds tracked by Wall St. Rank held Audentes Therapeutics, Inc as of Q1 2020.

Based on Jane Street's 13F filing for Q1 2020, filed 15 May 2020.